These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28429547)

  • 21. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of bone turnover markers to predict mineral and bone disorder in men with pre-dialysis non-diabetic chronic kidney disease.
    Davina JJ; Priyadarssini M; Rajappa M; Parameswaran S; Sahoo J; Mohan Raj PS; Revathy G; Palanivel C; Marella MG
    Clin Chim Acta; 2017 Jun; 469():195-200. PubMed ID: 28414058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.
    Haarhaus M; Fernström A; Magnusson M; Magnusson P
    Nephrol Dial Transplant; 2009 Nov; 24(11):3382-9. PubMed ID: 19542194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race.
    Soeiro EMD; Castro L; Menezes R; Elias RM; Dos Reis LM; Jorgetti V; Moysés RMA
    Pediatr Nephrol; 2020 Jul; 35(7):1297-1305. PubMed ID: 32157445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. News on biomarkers in CKD-MBD.
    Mazzaferro S; Tartaglione L; Rotondi S; Bover J; Goldsmith D; Pasquali M
    Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical parameters of bone turnover in kidney transplant recipients.
    Smalcelj R; Kusec V; Puretić Z; Mareković Z
    Wien Klin Wochenschr; 1998 May; 110(9):326-30. PubMed ID: 9629624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers of Bone Turnover Identify Subsets of Chronic Kidney Disease Patients at Higher Risk for Fracture.
    Hughes-Austin JM; Katz R; Semba RD; Kritchevsky SB; Bauer DC; Sarnak MJ; Ginsberg C; Shlipak MG; Lima F; Malluche HH; Ix JH
    J Clin Endocrinol Metab; 2020 Aug; 105(8):e2903-11. PubMed ID: 32474604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?
    Tan SJ; Cai MM
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():14-18. PubMed ID: 28429560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD).
    Misof BM; Blouin S; Roschger P; Werzowa J; Klaushofer K; Lehmann G
    J Musculoskelet Neuronal Interact; 2019 Jun; 19(2):196-206. PubMed ID: 31186390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
    Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
    Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
    Inaba M; Okuno S; Nagayama H; Yamada S; Ishimura E; Imanishi Y; Shoji S
    J Ren Nutr; 2015 Mar; 25(2):242-6. PubMed ID: 25556148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian rhythm of markers of bone turnover in patients with chronic kidney disease.
    Hansen D; Bressendorff I; Nordholm A; Møller AS; Klausen TW; Jørgensen NR
    Bone Rep; 2022 Jun; 16():101593. PubMed ID: 35663376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease.
    de Oliveira RA; Barreto FC; Mendes M; dos Reis LM; Castro JH; Britto ZM; Marques ID; Carvalho AB; Moysés RM; Jorgetti V
    Kidney Int; 2015 May; 87(5):1039-45. PubMed ID: 25493951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone Disorders in Chronic Kidney Disease: An Update in Diagnosis and Management.
    Babayev R; Nickolas TL
    Semin Dial; 2015; 28(6):645-53. PubMed ID: 26332760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating biochemical markers of bone remodeling in uremic patients.
    Ureña P; De Vernejoul MC
    Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers.
    Withold W
    Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):785-99. PubMed ID: 8933101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.